Send feedback

TSC2 p.Ala862Val

c.2585C>T · rs45517249 · VCV50078

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 10 submitters
AlphaMissense
ambiguous
0.4354 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0134%, eas)
Conditions
3
tuberous sclerosis 2

Computational evidence

Protein change
AlphaMissense0.4354ambiguous
REVEL0.55indeterminate
SaProtLLR -6.30tolerated
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.6GERP 2, phastCons 1
Regional constrainto/e 1.00unconstrained · MANE · 37 kb · p 0.88 · regional, not allelic
Overall
CADD22.9PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0134% East Asian · 6/44,898 alleles
Filtering AF 0.00579% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00394%
Overall 0.00198% 32/1,612,970 alleles · ultra-rare
Ancestry group Frequency 1 in
East Asiangrpmax 0.0134% 7,483
Remaining individualsnot grpmax-eligible 0.0032% 31,234
South Asian 0.0022% 45,546
European (non-Finnish) 0.00178% 56,191
Finnishnot grpmax-eligible 0.00159% 62,964

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TSC2
Protein
p.Ala862Val
Coding
c.2585C>T
MANE Select
NM_000548
dbSNP
rs45517249
Type
single nucleotide variant
Location
chr16:2075838 (GRCh38)
Gene constraint
LOEUF 0.203 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 68.81 · 2 PDB
Residue 862
an α-helix; a UniProt-annotated variant site (in)
Full TSC2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

tuberous sclerosis 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: tuberous sclerosishereditary neoplastic syndrome

For Tuberous sclerosis complex (Orphanet):

Inheritance
Autosomal dominant
Onset
All ages
Prevalence
1-9 / 100 000 (Taiwan, Province of China)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tsc2-p-ala862val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown